Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) has announced its participation in the Latin America Pain Society (LAPS) Annual Congress from September 5-7, 2024, in Mexico City. The company, which specializes in designing and manufacturing innovative medical devices for spinal surgery, will showcase its latest advancements in minimally invasive spinal devices and pain management solutions.
The LAPS conference provides Aurora Spine with a platform to present technologies aimed at optimizing patient care, reducing recovery times, and improving quality of life. The event brings together nationally and internationally renowned experts in pain management, offering opportunities for knowledge sharing and peer interaction. Matt Goldstone, Chief Commercial Officer of Aurora Spine, expressed excitement about participating in the conference and showcasing the company's cutting-edge advances and state-of-the-art technologies for better patient care.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha annunciato la sua partecipazione al Congresso Annuale della Società del Dolore dell'America Latina (LAPS), che si svolgerà dal 5 al 7 settembre 2024, a Città del Messico. L'azienda, specializzata nella progettazione e produzione di dispositivi medici innovativi per la chirurgia spinale, presenterà i suoi ultimi progressi in dispositivi spinali minimamente invasivi e soluzioni per la gestione del dolore.
La conferenza LAPS offre ad Aurora Spine una piattaforma per presentare tecnologie volte a ottimizzare le cure per i pazienti, ridurre i tempi di recupero e migliorare la qualità della vita. L'evento riunisce esperti di fama nazionale e internazionale nella gestione del dolore, offrendo opportunità di condivisione delle conoscenze e interazione tra pari. Matt Goldstone, Chief Commercial Officer di Aurora Spine, ha espresso entusiasmo per la partecipazione alla conferenza e per la possibilità di presentare i progressi all'avanguardia dell'azienda e le tecnologie all'avanguardia per una migliore cura dei pazienti.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha anunciado su participación en el Congreso Anual de la Sociedad del Dolor de América Latina (LAPS), que se llevará a cabo del 5 al 7 de septiembre de 2024, en la Ciudad de México. La empresa, especializada en el diseño y fabricación de dispositivos médicos innovadores para la cirugía de columna, mostrará sus últimos avances en dispositivos espinales mínimamente invasivos y soluciones para el manejo del dolor.
La conferencia LAPS proporciona a Aurora Spine una plataforma para presentar tecnologías destinadas a optimizar la atención al paciente, reducir los tiempos de recuperación y mejorar la calidad de vida. El evento reúne a expertos de renombre nacional e internacional en el manejo del dolor, ofreciendo oportunidades para el intercambio de conocimientos y la interacción entre pares. Matt Goldstone, Director Comercial de Aurora Spine, expresó su entusiasmo por participar en la conferencia y mostrar los avances de vanguardia de la empresa y tecnologías de última generación para una mejor atención al paciente.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF)는 2024년 9월 5일부터 7일까지 멕시코 시티에서 열리는 라틴 아메리카 통증 학회(LAPS) 연례 회의에 참가한다고 발표했습니다. 척추 수술을 위한 혁신적인 의료 기기를 설계하고 제조하는 데 특화된 이 회사는 최소 침습 척추 기기 및 통증 관리 솔루션 분야에서 최신 발전을 선보일 예정입니다.
LAPS 회의는 Aurora Spine에 환자 치료 최적화, 회복 시간 단축 및 삶의 질 향상을 목표로 하는 기술을 발표할 수 있는 플랫폼을 제공합니다. 이 이벤트는 통증 관리 분야에서 국내외 저명한 전문가들을 모아 지식 공유 및 동료 간 상호작용의 기회를 제공합니다. Aurora Spine의 최고 상업 책임자(Matt Goldstone)는 회의에 참가하게 되어 기쁘며, 환자 치료를 위한 회사의 최첨단 발전과 첨단 기술을 선보일 수 있기를 기대한다고 밝혔습니다.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) a annoncé sa participation au Congrès Annuel de la Société de la Douleur d'Amérique Latine (LAPS), qui se déroulera du 5 au 7 septembre 2024 à Mexico. L'entreprise, spécialisée dans la conception et la fabrication de dispositifs médicaux innovants pour la chirurgie de la colonne vertébrale, présentera ses dernières avancées en matière de dispositifs spinal minimaux invasifs et de solutions pour la gestion de la douleur.
La conférence LAPS offre à Aurora Spine une plateforme pour présenter des technologies visant à optimiser les soins aux patients, réduire les temps de récupération et améliorer la qualité de vie. Cet événement réunit des experts nationaux et internationaux renommés dans le domaine de la gestion de la douleur, offrant des opportunités d'échange de connaissances et d'interaction entre pairs. Matt Goldstone, directeur commercial d'Aurora Spine, a exprimé son enthousiasme à participer à la conférence et à présenter les avancées à la pointe de la technologie de l'entreprise pour une meilleure prise en charge des patients.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) hat seine Teilnahme am Jahreskongress der Lateinamerikanischen Schmergesellschaft (LAPS) angekündigt, der vom 5. bis 7. September 2024 in Mexiko-Stadt stattfinden wird. Das Unternehmen, das auf die Entwicklung und Herstellung innovativer medizinischer Geräte für die Wirbelsäulenchirurgie spezialisiert ist, wird seine neuesten Fortschritte in minimalinvasiven Wirbelsäulengeräten und Schmerzmanagementlösungen präsentieren.
Die LAPS-Konferenz bietet Aurora Spine eine Plattform, um Technologien vorzustellen, die darauf abzielen, die Patientenversorgung zu optimieren, die Erholungszeiten zu verkürzen und die Lebensqualität zu verbessern. Die Veranstaltung vereint national und international renommierte Experten im Bereich Schmerzmanagement und bietet Gelegenheiten zum Wissensaustausch und zur Interaktion mit Fachkollegen. Matt Goldstone, Chief Commercial Officer von Aurora Spine, äußerte seine Begeisterung über die Teilnahme an der Konferenz und die Präsentation der wegweisenden Fortschritte und hochmodernen Technologien des Unternehmens zur Verbesserung der Patientenversorgung.
- None.
- None.
CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its participation in the upcoming Latin America Pain Society (LAPS) Annual Congress September 5-7, 2024, in Mexico City.
The event will provide Aurora Spine with a platform to present its latest advancements in minimally invasive spinal devices and pain management solutions. These technologies are designed to optimize patient care, reduce recovery times, and improve quality of life. Aurora Spine’s cutting-edge developments focus on addressing the unique challenges in spine and pain treatment, positioning the company as a pioneer in the medical device industry.
This world-class LAPS congress presents outstanding, nationally and internationally renowned experts in pain management to share their knowledge and present the opportunity to interact with peers.
Matt Goldstone, Chief Commercial Officer of Aurora Spine, stated, “We are very excited to be participating in this year’s LAPS Conference. This world-class LAPS Congress showcases cutting-edge advances and state-of-the-art technologies to present the latest research, techniques and products for better patient care.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant and pain markets through a series of innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine is an emerging growth company focused on bringing new solutions to the spinal implant and pain care markets through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
FAQ
When and where is Aurora Spine (ASAPF) attending the LAPS Conference in 2024?
What will Aurora Spine (ASAPF) showcase at the LAPS Conference 2024?
How does Aurora Spine (ASAPF) aim to improve patient care through its technologies?
Who from Aurora Spine (ASAPF) commented on the company's participation in the LAPS Conference 2024?
